recent articles
Agilent: Providing a comprehensive digital diagnostic pathology system for enhanced clinical utility SANTA CLARA, Calif., March 08, 2023 Agilent Technologies Inc. (NYSE: A) today announced a multi-year distribution agreement with...
Akoya Collaborating with Agilent to Catalyze Precision Medicine We recently announced a partnership with Agilent to develop multiplex diagnostic solutions for tissue analysis and to commercialize workflow solutions for these...
Agilent and Akoya Biosciences: Will commercialize end-to-end workflow solutions for tissue biomarker analysis in companion diagnostic development SANTA CLARA, Calif, & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Agilent Technologies,...
Agilent Technologies Inc. (NYSE: A), a leader in life sciences, diagnostics, and applied chemical markets, and Visiopharm, a leader in AI-based digital pathology, today announced the signing of a worldwide distribution agreement, enabling...
Visiopharm & Agilent Co-Sponsoring Transforming Digital Pathol...
- Advocacy
- Anatomic Pathology
- Business
- Clinical Laboratories
- Conferences
- Current Affairs
- Data Management
- Digital Pathology Conferences
- Digital Pathology News
- Education
- Health Technology Collaboration
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Informatics
- Laboratory Management & Operations
- Pathology News
- Vendor products
- Web/Tech
- Whole slide
We hope to see you during the joint Visiopharm & Agilent presentation at DigiBase’s complimentary Transforming Digital Pathology webinar! Accelerating Accurate Diagnosis APRIL 30, 2021 | 6:25AM-7:15am (EST) | 11:25AM-12:15PM (BST) |...
CEO Profile: Applied Spectral Imaging’s Limor Shiposh
- Advocacy
- Anatomic Pathology
- Clinical Laboratories
- Clinical Pathology
- Device Manufacturers
- Digital Pathology News
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Informatics
- Laboratory Management & Operations
- Marketing
- Medical Research
- Microscopy
- Pathology News
- Personal
- TeleHealth
- Vendor products
- Web/Tech
This is the fourth in a series of CEO short interviews about their views on their company, the digital pathology market, lessons learned and perhaps a little insight into their business principles. My personal thanks to Ms. Shiposh and the...